Congress Enacts Clean Reauthorization Of FDA User Fees, Leaving Uncertain Future For Important Policy Reforms - Life Sciences, Biotechnology & Nanotechnology
On September 30, 2022, Congress passed a short-term continuing resolution ("CR"), H.R. 6833, as a temporary stopgap measure to continue funding the U.S. government past the end of the fiscal year.
Drug Administration Safety Pharmaceuticals For Children Program Office Of Critical Foods Members Of Congress Drug Administration Senate Health
Source: mondaq.com